Neovii competitors and similar companiesClear all
Neovii's competitors and similar companies include Atengen, Susavion Biosciences and Amal Therapeutics.
 Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
|  Atengen Atengen is a biotechnology company providing a therapeutic target that is expressed specifically in tumor blood vessels of most types of solid tumors. |  Susavion Biosciences Susavion Bioscience is a biotechnology company formed to advance technology based on discovery of multi-valent, bio-active peptides that mimic carbohydrate ligands of lectin-type receptors suitable for use as therapeutic modulators of the immune system. |  Amal Therapeutics Amal Therapeutics is a biotech company, which engages in the research and development of therapeutic vaccines in oncology. | |
Founding Date | Founding Date 2003 | Founding Date 2017 | Founding Date 2006 | Founding Date N/A |
Type | Type Private | Type Private | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US | Locations HQ | Locations Tempe, US HQ | Locations Genève, CH HQ |
Employees | Employees 921% increase | Employees 1 | Employees 4 | Employees 25 |
Alexa Website Rank | Alexa Website Rank N/A | Alexa Website Rank 449450 | Alexa Website Rank 572352 | Alexa Website Rank N/A |
For sources of this data, please see the company profile
View company profiles
Atengen
HQ
Employees
1
Atengen is a biotechnology company providing a therapeutic target that is expressed specifically in tumor blood vessels of most types of solid tumors.
View companySusavion Biosciences
HQ
Tempe, US
Employees
4
Susavion Bioscience is a biotechnology company formed to advance technology based on discovery of multi-valent, bio-active peptides that mimic carbohydrate ligands of lectin-type receptors suitable for use as therapeutic modulators of the immune system.
View companyAmal Therapeutics
HQ
Genève, CH
Amal Therapeutics is a biotech company, which engages in the research and development of therapeutic vaccines in oncology.
View company